TWST 250516 50.00C(TWST250516C50000) Stock Price Today

Clear

All

Quotes

News

Learn

Help

All

News

Announcements

No matches yet

Operations too frequent. Please try again later.

Please check network settings and try again Refresh Refresh

History record

TWST250516C50000

Watchlist

0.50
0.000.00%

15min DelayClose May 8 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Twist Bioscience And Ginkgo Bioworks Announces Revision In Its Three-Year $15M Collaboration Including Ginkgo Receiving Preferential Pricing With No Required Minimum Purchase Volume
BenzingaMay 8 08:13 ET
Express News | Twist Bioscience Corp - Ginkgo to Order From Twist With No Purchase Minimums
ReutersMay 8 08:01 ET
Express News | Twist Bioscience Corp - Receives License to Long DNA Technology Under New Terms
ReutersMay 8 08:01 ET
Express News | Twist Bioscience and Ginkgo Bioworks Revise Collaboration
ReutersMay 8 08:00 ET
New Analyst Forecast: $TWST Given $44.0 Price Target
Quiver QuantitativeMay 7 18:23 ET
J.P. Morgan Maintains Twist Bioscience(TWST.US) With Sell Rating, Cuts Target Price to $33
Moomoo NewsMay 7 02:41 ET · Ratings

Comments

Teddy123

Mar 11 19:33

Twist Bioscience Offers Clonal Genes for Global Academic Researchers at Express Speed for No Extra Cost

$Twist Bioscience (TWST.US)$
Academic Breakthrough: Twist Bioscience Now Offers 4-Day Gene Synthesis at Zero Extra Cost

Analysts Notebook

Feb 13 19:50

Columns Interest in AI-Powered MedTech is on the Rise: Key Stocks to Watch

The attention of AI Medteck stocks are rapidly increasing.
Pelosi's new holdings have doubled $Tempus AI (TEM.US)$ value in just a few weeks, and $Firefly Neuroscience (AIFF.US)$'s inclusion in NVIDIA's Connect program has also caused its stock price to soar.
In addition, DeepSeek's rapid rise has boosted the AI application sector, particularly in medicine/healthcare. Cathie Wood believes medical AI is undervalued, with untapped pot...

117

285

Moomoo News Global

Feb 6 17:43

Columns AI Healthcare-tech May Be the Next Big Thing. Here's Why

US Congress member Nancy Pelosi and Ark Invest's Cathie Wood both bet big on an AI stock recently.
The stock in question is $Tempus AI (TEM.US)$, a company that uses data and artificial intelligence (AI) to create precision medicine services. ARK Invest, a prominent advocate for innovative technologies, first showed interest on December 6, when it purchased shares in this healthcare technology firm. Since that initial investment, Tempus AI h...

154

ClydePeternuts

Sep 12, 2024 15:17

Cathie Wood and Ark Invest's trade activity from today 9/10
$ARK Innovation ETF (ARKK.US)$ :
Bought $Advanced Micro Devices (AMD.US)$ $DraftKings (DKNG.US)$ $Tempus AI (TEM.US)$
Sold $Unity Software (U.US)$ $Palantir (PLTR.US)$ $Twist Bioscience (TWST.US)$ $Veracyte (VCYT.US)$
By the way..
Palantir $PLTR is on fire this year
It's up over 109% YTD, just got included in the S&P500, and today Bank of America raised their price target to $50 a share
D. E. Shaw owns almost $500 million worth of shares, more than any...

ClydePeternuts

Jul 17, 2024 16:06

Cathie Wood and Ark Invest's trade activity from 2024/07/16

Buys🟢\\ $Beam Therapeutics (BEAM.US)$ $Oklo Inc (OKLO.US)$
Sells🔴\\ $Zoom Communications (ZM.US)$ $Trimble (TRMB.US)$ $Twist Bioscience (TWST.US)$ $UiPath (PATH.US)$